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The present study was to determine the anticancer potential of Labisia pumila in in vitro models. Results from the study revealed
that ethanol extract of L. pumila was more cytotoxic against HM3KO cells while having reduced eﬀects on nonmalignant cells as
compared to aqueous and hexane extracts. Thus, ethanol extract was selected to be further separated by using the bioassay-guided
fractionation method to give an active fraction, SF2Lp. Results obtained from the ﬂow cytometry analysis showed that SF2Lp was
able to arrest the HM3KO cell cycle at the G1 phase, while morphological ﬁndings from AO-EB nuclear staining assays along with
the Apoptotic Index conﬁrmed the induction of apoptosis by SF2Lp in HM3KO cells. Results from the mechanistic study further
revealed that SF2Lp treatment was able to concurrently increase the expression level of p53 and pro-apoptotic protein Bax and
also reduce the expression level of anti-apoptotic protein BCl-2 in HM3KO cells, directly contributing to the increase in Bax/Bcl-2
ratio. These ﬁndings, therefore, suggested that L. pumila was able to inhibit HM3KO cell growth possibly by arresting the cell cycle
at G1 phase and inducing apoptosis in HM3KO cells via the up- and down-regulation of Bax/Bcl-2 protein, mediated through a
p53-dependent pathway.
1.Introduction
Natural products of various sources, particularly from plants
and marines have been regarded as a precious alternative to
modern medicine and investigations on active components
with anticancer potential of natural sources have been exten-
sively carried out [1–4].
There is an increasing understanding that chemothera-
peutic agents and a variety of anticancer agents can stimulate
cancer cell death by way of apoptosis [5–8]. Apoptosis,
a highly structured and orchestrated process, performs a
signiﬁcant role in regulating cell number for the growth
and homeostasis of tissues by eliminating aged, damaged,
and unwanted cells [9, 10]. In cancer treatment, one of the
approaches to restrain tumor growth is by activating the
apoptotic machinery in the tumor cells [11, 12].
Earlierstudiesdonerevealedthatextractsfromtheplants
ofMyrsinaceaeexhibitedanticancerpotentialinbothinvitro
or in vivo models [13–15]. Labisia pumila (L. pumila), or
locally recognized as Kacip Fatimah from the family Myrsi-
naceae, is a famous Malaysian traditional herbs that has been
exploited especially by the Malay women for generations for
pre- and postpartum treatments [16, 17]. Other applications
of L. pumila include treatment of dysentery, dysmenorrhea,
ﬂatulence, gonorrhea, and “sickness in the bones” [16, 18].
Of late, the herb has been extensively commercialized in
Malaysia as health tonic drink and supplement capsules
especially for women.
Scientiﬁc studies done on L. pumila were very scarce and
published data on the pharmacological activity of this plant
were very limited. Several scientiﬁc studies done on L.
pumila revealed that L. pumila a q u e o u se x t r a c tw a sf o u n d2 Evidence-Based Complementary and Alternative Medicine
to have compounds with oestrogenic activities [19]a n dw a s
able to reduce the level of cortisol in pregnant lab rats
without aﬀecting the status of the immune system [20]. In a
diﬀerent study, the water extract of this plant demonstrated
protective eﬀect on UV-irradiated human dermal ﬁbroblasts,
and the eﬀect was found better than ascorbic acid in
defending the skin against UV-induced photoaging [21].
Besides these reports, published scientiﬁc ﬁndings regarding
anticancer potential of L. pumila in vitro have not yet been
reported. Thus, this study was intended to investigate the
antiproliferative potential of L. pumila ethanol extract and
its active fraction in in vitro model and also to determine
the molecular mechanism involved during the induction
of apoptosis in human melanoma HM3KO cells. To the
best of our knowledge, this is the ﬁrst information on the
antiproliferative and proapoptotic eﬀects of L. pumila in
human melanoma HM3KO cells in vitro.
2.MaterialsandMethods
2.1. Plant Material. Dried powder of L. pumila whole plant
was supplied by Professor Dr. Azimahtol Hawariah Lope
Pihie (National University of Malaysia).
2.2. Plant Extraction. In this study, the dry powder of L.
pumila whole plant was separately extracted with hexane,
ethanol, and water. For the preparation of ethanol and
hexane extracts, L. pumila whole plant powder was weighed
and exhaustively extracted with 90% ethanol and absolute
hexane (1g/10mL, w/v), respectively, by using a Soxhlet
apparatus at a temperature of 40–50◦Cf o r8h o u r s .T h e
extracts obtained were then ﬁltered through No. 2 Whatman
ﬁlter paper and both ﬁltrates were dried at 40◦Cu n d e r
reduced pressure by using a rotary evaporator. As for the
aqueous extract, it was prepared by heating L. pumila whole
plant powder with distilled water (1g/10mL, w/v) at a tem-
perature of 60◦C for 8 hours. The resultant extract was then
ﬁltered through No. 2 Whatman ﬁlter paper, and the ﬁltrate
was freeze-dried by using a freeze-dryer.
2.3. Preparation of Samples. To determine the antiprolifera-
tive activity of L. pumila, all dried hexane (LpHE), ethanol
(LpEE), and aqueous (LpAE) extracts were weighed and
dissolved in dimethyl sulphoxide (DMSO) to an appropriate
concentration and stored as a stock solution at −20◦C until
used. The ﬁnal concentration of DMSO used was less than
1%, and at this concentration, DMSO does not aﬀect cell
viability [22]. For the treatment of experimental cultures,
each stock of extracts was diluted with fresh Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) enriched with 10% (v/v)
fetal bovine serum (FBS) and 1% antibiotic (Penicillin and
Streptomycin) cocktail to give ﬁnal concentrations of L.
pumila extracts ranging from 0 to 5mg/mL.
Active fraction of L. pumila was prepared from the
most active extract by using column chromatography, where
chloroformwithanincreasingamountofmethanolwasused
as the eluent. Fractions collected were then subjected to thin
layer chromatography (TLC) using methanol:chloroform
(1:9) as the mobile phase. Fractions with the same TLC
proﬁle were pooled and dried to give a few main fractions.
The fraction with most yield was then chosen for further
separation and rechromatographed and fractions collected
were then underwent TLC proﬁling to give main fractions.
These fractions were then subjected to antiproliferative assay
against HM3KO cells to select the most active fraction. The
selectedactivefractionwasthendilutedinDMSOtogenerate
various concentrations based on its IC50 value, to be further
investigated in the apoptosis assay, cell cycle progression, and
Western blot analyses.
2.4. Chemicals. Dacarbazine or 5-(3,3-Dimethyl-1-triazen-
yl)imidazole-4-carboxamide or DTIC, ethylenediamine tet-
raacetic acid (EDTA), ribonuclease A (RNase A), dimethyl
sulfoxide (DMSO), proteinase K, acridine orange, ethidium
bromide, and propidium iodide were purchased from Sigma
Chemical Co (St. Louis, MO, USA). Dulbecco’s modiﬁed
Eagle’sMedium(DMEM),trypsin,fetalbovineserum(FBS),
EDTA, and penicillin-streptomycin were purchased from
Gibco Laboratories, New York, while fungizone was bought
from Flowlab, Australia.
The antibodies against Bax (clone 6A7), Bcl-2 (clone Bc-
12/100), and p53 (clone Pab 1801) were purchased from
Pharmingen (USA). The antibody against β actin was from
Sigma Aldrich. Bradford reagent was from Bio-Rad labora-
tories (USA) and Renaissance Western blot Chemilumines-
cencereagentPluswasfromPerkinElmer(Boston,USA).All
other chemicals used in this study were of the highest grade
available.
2.5. Cell Culture. Human melanoma HM3KO cells were
kindlyprovidedbyDrYokoFunasaka,Japan,whereasMDBK
and Vero cells were purchased from American Type Cell
CultureCollection(ATCC),Maryland,USA.Thesecellswere
cultured in DMEM supplemented with 10% fetal bovine
serum, penicillin-streptomycin, fungizone, and miramycin.
The cells were maintained in a humidiﬁed incubator at 37◦C
with 5% CO2 and 95% air. The cells were regularly observed
using an inverted microscope.
2.6.CellProliferationAssay. TheantiproliferativeeﬀectsofL.
pumila various extracts (hexane-LpHE, ethanol-LpEE, and
aqueous-LpAE) were investigated by determining their IC50
values. Cells were cultured in supplemented DMEM in a
humidiﬁedatmospherewith5%CO2 at37◦C.Whenthecells
reached 70–80% conﬂuency, these logarithmically growing
cells were then rinsed with phosphate buﬀered saline (PBS)
before being trypsinized with 0.025% trypsin. Cells (1×105)
w e r et h e np l a t e di na9 6 - w e l lp l a t ea n dp e r m i t t e dt oa d h e r e
for 8–12h. On the following day, old media were discarded
and all cells were rinsed with PBS. Fresh supplemented
DMEM was then loaded into each well and cells were then
treated with various concentrations (0–5mg/mL) of LpAE,
LpEE, and LpHE, 1% DMSO (served as negative control),
and Dacarbazine (positive control). Dacarbazine was chosen
to be used as positive control because it is one of the
most active approved neoplastic agents for the treatment of
malignant melanoma [23]. The treated and untreated cells
were then incubated for 24, 48, and 72 hours at 37◦Ci nEvidence-Based Complementary and Alternative Medicine 3
an atmosphere of 5% CO2 and 95% air. At the end of each
indicated time, the antiproliferative activity of all extracts
was assessed by using methylene blue method as previously
described [24]. The absorbance of dissolved solutions was
measured by an ELISA reader at a wavelength of 660nm.
EachconcentrationofLpAE,LpEE,andLpHEwasassayedin
triplicates, the absorbance of untreated cells was considered
as 100%, and the cytotoxic dose that kills 50% of cells
population (IC50) was determined from the absorbance
versus concentration curve. The above-mentioned method
also was used to determine the IC50 value of L. pumila active
fraction.
2.7. Cell Cycle Analysis by Flow Cytometry. The eﬀects of L.
pumila on cell proliferation was further studied using its
active fraction. In order to determine the eﬀect of L. pumila
on the cell cycle, ﬂow cytometry analysis was carried out. For
this purpose, cells were seeded in 6-well plates at a density of
1 ×105 cells/mL for 24h. After incubation, cells were treated
with diﬀerent concentrations of the active fraction based on
its IC50 value. Floating and attached cells were harvested,
rinsed in PBS, ﬁxed in ice-cold ethanol (70% v/v), and kept
at −20◦C for 30 minutes. After incubation, the mixture was
centrifuged for 5min at 600×ga t4 ◦C, and the resultant
pellet was further treated with DNase-RNase A at 2mg/mL
for 30min. The cell pellet was then stained with propidium
iodide (50μg/mL), containing 0.1% Triton X-100 and EDTA
(0.02mg/mL). Cell cycle proﬁles were determined by using
Cyan software (Dako Cytomation, Germany).
2.8. Apoptosis Assay. The antiproliferative activity of L.
pumila most active fraction was further investigated by
apoptosis assay to determine the mode of cell death involved.
For this purpose, treated and untreated cells were subjected
to Giemsa staining, and the induction of apoptosis was
further conﬁrmed by acridine orange-ethidium bromide
(AO-EB) double-staining.
For Giemsa staining, cells were seeded at 1×105 cells/mL
on glass slides for 24h to allow cell adherence. After incuba-
tion, cells were then treated with the concentration of IC50
of L. pumila most active fraction for 24, 48, and 72 hours.
At the end of the treatment, the cells were rinsed twice with
cold PBS and further ﬁxed with 100% cold methanol for 15
minutes. Cells were then stained with Giemsa for 30 minutes
and rinsed under running tap water and air-dried before
being observed under a light microscope.
As for the AO-EB staining, cells were seeded at 1 ×
105 cells/mL in 6-well plates for 24h to allow cell adherence.
After incubation, cells were treated with the concentration
of IC50 of L. pumila most active fraction for 24, 48, and 72
hours. At the end of the treatment, cells were trypsinized
with 0.025% (w/v) trypsin solution and rinsed with PBS
once. Twenty-ﬁve (25)μL of the cell suspension was then
mixed together with 1μL of AO-EB dye cocktail, containing
100mg/mL of each dye. Cells were immediately visualized
under a ﬂuorescence microscope. The quantiﬁcation of
apoptotic cells was according to Ribble et al. [25], where
apoptotic cells showed green or orange condensed or frag-
mented chromatin. At least 600 nuclei per pellet were scored
using a ﬂuorescence microscope at a magniﬁcation of 400x
and the percentage of apoptotic cells were determined as
follows [26]:
Apoptotic cells, % =
apoptotic cell number
total number

×100.
(1)
2.9. Western Blot Analysis. To determine the eﬀect of L.
pumila on protein expression of Bax, Bcl-2, p53, and
caspases-9, -7, and -8 in HM3KO cells, cells were seeded
in 6-well plates at a density of 1 × 105 cells/mL for 24h.
After incubation, cells were treated with the concentration
of IC50 value of L. pumila most active fraction for 3, 6, and
24 hours. After incubation of each indicated times, the cells
were scrapped in extraction buﬀer containing 50mM Tris-
HCl (pH 8.0), 150mM NaCl, 5mM EDTA, 5mM EGTA,
1% (v/v) Triton-X, 1mM phenylmethylsulfonyl ﬂuoride
(PMSF),10mMglycerophosphate,1mMNa3VO4,10μg/mL
pepstatin A, 10μg/mL aprotinin, 20μg/mL leupeptin, and
5mM DTT. The mixture was then put on ice for 45
minutes and further subjected to three freeze-thaw cycles
and was then centrifuged at 10,000rpm for 20min at 4◦C.
The protein concentration was determined by DC Bio-Rad
protein assay according to the manufacturer’s instructions.
ForWesternblot analysis,30ug ofproteins fromboth treated
and untreated cells was subjected to separation by using
SDS-PAGE over 4–12% gradient gels. After electrophoresis,
the separated proteins were blotted or transferred onto
polyvinyl-diﬂuoride (PVDF) membrane (PolyScreen, NEN
Life Sciences, USA). The membrane was then dried and
blocked in blocking buﬀer (5% nonfat dry milk in PBS-
Tween (0.1%) for 1h at room temperature and further incu-
bated with appropriate primary antibody in blocking buﬀer
overnight at 4◦C. This was followed by incubation with the
appropriate secondary antibody coupled to horseradish per-
oxidase (HRP). The resultant immunoreactive bands were
detected by Renaissance Western Blot Chemiluminescence
ReagentPlus(NEN,PerkinElmer,USA),exposedonaKodak
OMAT X-ray ﬁlm (Eastman Kodak), and further subjected
to a densitometry analysis, which was performed using a GS
670 Imaging Densitometer with Molecular Analyst software
(Bio-Rad, Hercules, USA). The membranes were reprobed
with β-actin antibodies as an internal control and to ensure
equal loading. Each Western blot shown is a representative of
at least three independent experiments.
2.10. Statistical Analysis. All data were expressed as the
means±standarddeviation(SD)ofthevaluesobtainedfrom
at least three replicates. Using analysis of variance (ANOVA),
statistical signiﬁcance was determined. Mean values with
probability values of P<0.05 were taken as statistically
signiﬁcant.
3. Results
3.1. Antiproliferative Activity of L. pumila Extracts and Its
Active Fraction. The antiproliferative activity of L. pumila
extracts was determined using a methylene blue assay, and4 Evidence-Based Complementary and Alternative Medicine
Table 1: Antiproliferative activity of L. pumila various extracts in human melanoma HM3KO and nonmalignant MDBK and Vero cell lines.
L. pumila extracts
IC50 values (μg/mL)
HM3KO MDBK Vero
LpAE 66.41 ±0.78 89.30 ±1.95 107.62 ± 0.98
LpEE 16.18 ±0.94 129.22 ± 1.37 76.74 ±0.86
LpHE 35.67 ±0.66 57.90 ±1.09 36.78 ±1.63
Dacarbazine 5.32 ±0.71 39.52 ±0.76 54.11 ±0.56
Allvalueswereexpressedasthemeans ± SDfromthreeindependentexperiments:L.pumilaaqueousextract-LpAE,ethanolextract-LpEE,andhexaneextract-
LpHE.
the IC50 values obtained were used as a parameter for
cytotoxicity. The IC50 is the concentration required for 50%
inhibition of a population of targeted cells [27], and crude
extracts with IC50 values lower than 30μg/mL are considered
cytotoxic [28].
Table 1 shows the antiproliferative activity of L. pumila
various extracts against human melanoma HM3KO and
nonmalignantMDBKandVerocelllines.Theethanolextract
(LpEE) was found more active against HM3KO cells, with
an IC50 values of 16.18 ± 0.94μg/mL as compared to LpAE
and LpHE (66.41 ± 0.78 and 35.67 ± 0.66μg/mL, resp.).
Interestingly, LpEE demonstrated a certain level of cytoselec-
tivity towards nonmalignant MDBK and Vero cell lines, with
higher IC50 values of 129.22 ±1.37 and 76.74 ± 0.86μg/mL,
respectively. Comparatively, dacarbazine, a neoplastic drug,
was used as a positive control in this study. Dacarbazine
is widely used to treat malignant melanoma. In this study,
dacarbazine exhibited an inhibition against HM3KO cells
with an IC50 value of 5.32 ± 0.71μg/mL. (Table 1).
As the results from the antiproliferative assays revealed
that ethanol extract of L. pumila (LpEE) was more cytotoxic
against HM3KO cells as compared to aqueous (LpAE) and
hexane (LpHE) extracts, thus LpEE was selected as the most
active extract. In view of this, LpEE was then subjected
to separation by using column chromatography and thin
layer chromatography. From the column chromatography
analyses, 131 fractions were collected and all of these
fractions were then subjected to thin layer chromatography
(TLC). Fractions with the same TLC proﬁle were pooled
and dried. Based on the TLC proﬁles obtained, these 131
fractions can be grouped into 9 major fractions (F1–F9). Of
this nine fractions, F2 and F3 exhibited lower IC50 values
of 9.3 ± 0.32 and 8.71 ± 0.41μg/mL, respectively. The rest
of the fractions showed IC50 values of more than 90μg/mL.
Even though F3 displayed values less than F2, F2 was chosen
for further separation because the total yield of F2 was 7.4
times more (26.40g) than F3 (3.58g). From the chromatog-
raphy analyses, F2 was successfully separated to 5 major
fractions, namely, SF1–SF5. These fractions were then tested
against HM3KO cells. Table 2 shows the antiproliferative
activity of L. pumila fractions (SF1–SF5) against HM3KO
cells.
As shown in Table 2, fraction SF2 was found more
eﬀective against HM3KO cells with IC50 values of 7.59 ±
0.53μg/mL as compared to other fractions. Thus, this active
fraction or designated as SF2Lp was then used to be further
Table 2: Antiproliferative activity of L. pumila various fractions
(SF1–SF5) against human melanoma HM3KO cells.
L. pumila fractions IC50 values (μg/mL)
SF1 35.80 ±0.27
SF2 7.59 ± 0.53
SF3 47.51 ±0.87
SF4 63.88 ±0.59
SF5 93.91 ±0.68
All values were expressed as the means ± SD from three independent
experiments.
investigated in the apoptosis assay, cell cycle progression, and
Western blot analyses.
3.2. Induction of Apoptosis by L. pumila Active Fraction,
SF2Lp. Results from the antiproliferative assay suggested
that fraction SF2 or termed as SF2Lp was the most active
fraction with the IC50 values of 7.59 ± 0.53μg/mL as com-
paredtootherfractions.Thisvalueappearedtobelowerthan
the IC50 value of active ethanol extract (16.18±0.94μg/mL),
indicating that SF2Lp is more cytotoxic to HM3KO cells
than its crude extract. To determine the mode of cell death
induced by L. pumila active fraction, SF2Lp in HM3KO cells,
the cells were treated with SF2Lp at 7.59μg/mL in diﬀerent
time intervals (24, 48, and 72 hours).
Under the phase contrast of an inverted microscope, the
morphological changes of unstained HM3KO cells undergo-
ing apoptosis can still be seen clearly (Figure 1). After 72-
hour treatment, healthy HM3KO cells were seen as attached
cells at the ﬂask’ surface, displaying regular epithelial-like
shape and less number of apoptotic cells (Figure 1(a)), while
SF2Lp-treated cells showed obvious morphological changes,
including cell shrinkage and reduced in number. Some
cells were spherical in shape indicating a degree of loss of
attachment (Figures 1(b), 1(c),a n d1(d)).
To detect the apoptotic cells, SF2Lp-treated cells were
subjected to Giemsa staining, and the Giemsa stained-cells
were observed under a light microscope. Microscopically,
the healthy HM3KO cells displayed an ordinary epithelial-
like shape with normal ratio of cytoplasm and nucleus
(Figure 2(a)). In SF2Lp-treated cells, the morphological
changes such as cytoplasmic condensation as well as highly
condensed nucleus of cells undergoing apoptosis can be seenEvidence-Based Complementary and Alternative Medicine 5
(a) (b)
(c) (d)
Figure 1: Representative images from morphological observation under phase contrast of an inverted microscope of SF2Lp-treated and
-untreated HM3KO cells. HM3KO cells were treated with 7.59μg/mL SF2Lp for 24 (b), 48 (c), and 72 (d) hours. A population of 72 hours
DMSO-treated HM3KO cells, which served as negative control, showed less apoptotic cells (a). Red arrows showed nuclear condensation
and cells shrinkage due to apoptosis which occurred actively at the beginning of the treatment and the presence of apoptotic bodies (black
arrows) after 72 hours of treatment. Magniﬁcation: 400x.
as early as 24-hour treatment. After 72-hour treatment the
number of viable cells observed was signiﬁcantly reduced
as most of SF2Lp-treated cells were dead and sloughed oﬀ,
leaving empty spaces behind (Figure 2(d)).
The inhibitory eﬀect of SF2Lp on HM3KO cells via incu-
bation of apoptosis was further conﬁrmed by using acridine
orange (AO) and ethidium bromide (EB) nuclear staining.
Acridine orange and ethidium bromide are two common
ﬂuorochromes that can be used to evaluate the nuclear
morphology of apoptotic cells. It has been suggested that
through this staining method, apoptotic index and cell
membrane integrity can be assessed simultaneously, and
as there is no cell ﬁxation step, a number of potential
artifacts thus can be avoided. In addition, ﬂuorescence
light microscopy together with AO-EB staining is a method
of choice for its accuracy, simplicity, and rapidity [29].
While AO permeates both live and dead cells and makes
the nuclei visibly green, EB only stains cells when their
cytoplasmicmembraneintegrityislostorcompromisedand,
therefore, stains the nucleus red [29, 30]. By means of AO-
EB staining assay, live cells exhibit normal green nuclei early
apoptotic cells show bright green nuclei with condensed or
fragmentedchromatin,lateapoptoticcellsdisplaycondensed
and fragmented orange chromatin, whereas necrotic cells
showed structurally normal orange nucleus [29].
Inthisstudy,HM3KOcellsweretreatedwithSF2Lpatthe
concentration of its IC50 values of 7.59μg/mL for 24, 48, and
72 hours. HM3KO cells treated with 1% DMSO were used as
control. Cells that showed bright green or orange condensed
or fragmented chromatin were taken as apoptotic [25].
Findings from the microscopic examination showed that
live HM3KO cells in the control group displayed normal
green nuclei (Figure 3(a)), while SF2Lp-treated cells showed
membrane blebbing and bright dense granular masses of
chromatin aggregated along the periphery of the nuclear
membrane, indicating early apoptosis (Figure 3(b),b l u ea r -
row). In some of the treated cells, the nuclei were found dis-
integrated and fragmented into distinct spherical fragments
with highly densed chromatin, suggesting the formation of
apoptotic bodies in late apoptosis (Figures 3(c) and 3(d),
green arrow). The percentage of apoptotic HM3KO cells for
each exposure time (24, 48, and 72 hours) to SF2Lp were6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Representative images from morphological observation of SF2Lp-treated and -untreated HM3KO cells stained with Giemsa.
HM3KO cells were treated with 7.59μg/mL SF2Lp for 24 (b), 48 (c), and 72 (d) hours. DMSO-treated HM3KO cells served as negative
control (a). SF2Lp-treated cells showed signiﬁcant morphological changes including shrinkage of cytoplasm and compaction of the nucleus
(red arrow), indicating that cells underwent apoptosis. Magniﬁcation: 400x.
calculated and the data were presented as Apoptotic Index
(AI) as displayed in Figure 4.
Theapoptotic index(AI)wasdeterminedtoconﬁrmthat
SF2Lp-treated cell death was through apoptosis and it was
calculated as the percentage of apoptotic cells from at least
600 counted cells within the cells population [26]. Apoptotic
Index (AI) can be deﬁned as the percentage of apoptotic
cells and apoptotic bodies within the overall population of
total cells [26]. The diﬀerences between the control group
and treated group (1% DMSO, 24 hours, 48 hours, and 72
hours) were statistically analyzed using ANOVA, where P
values < 0.05 were considered as signiﬁcant.
As shown in Figure 4, results from the study showed that
the percentage of apoptotic HM3KO cells that have been
treated with 7.59μg/mL of L. pumila active fraction, SF2Lp,
wereincreasedinatime-dependentmannerwith29.5±1.6%
at 24 hours, 54.1 ± 1.1% at 48 hours, and 69.8 ± 1.7%
at 72 hours. Untreated HM3KO cells that were cultured in
enriched DMEM showed that only 4.3 ± 0.4% of these cell
were apoptotic. On the other hand, cells that have been
treated with 1% DMSO as negative control displayed only
5.7±0.9% apoptotic cells and this value was not signiﬁcantly
diﬀerent (P<0.05) as compared to untreated control cells.
This observation indicated that longer the exposure time to
SF2Lp, the higher the percentage of apoptotic HM3KO cells.
3.3. Active Fraction of L. pumila, SF2Lp-Induced Cell Cycle
Arrest at G1 Phase in HM3KO Cells. C e l lc y c l ea n a l y s e sw e r e
performed to investigate the basis of antiproliferative activity
of L. pumila active fraction, SF2Lp, in HM3KO cells by ﬂow
cytometry analysis, and for this purpose, cells were treated
with 3.00, 7.59, and 15.00μg/mL of SF2Lp for 24 hours.
The concentrations were chosen based on the IC50 values of
SF2Lp against HM3KO cells. The G1/S ratio was used as an
index of G1 arrest [31].
As shown in Figure 5, after 24 hours treatment, at the
concentrationof3,7.59,and15μg/mLofSF2Lp,thepercent-
ageofcellsinG1phasereachedto65.58±1.5,62.52±0.8,and
57.83 ± 1.4%, respectively, of total cells when compared to
53.85±1.1%inthecontrolgroup(P<0.05).Inaddition,the
percentageofcellsintheSphaseweresigniﬁcantly(P<0.05)
declinedfrom15.22±1.0%inthecontrolgroupto7.97±0.9,
5.61 ± 0.5, and 4.54 ± 0.5%, in the SF2Lp-3, SF2Lp-7.59,
and SF2Lp-15 group, respectively, with a slight increase from
6.25 ± 0.9 in the control group to 10.93 ± 0.7, 11.87 ± 0.7,
and 17.63±0.5% in the SF2Lp-3, SF2Lp-7.59, and SF2Lp-15Evidence-Based Complementary and Alternative Medicine 7
(a) (b)
(c) (d)
Figure 3: Representative images from morphological observation of SF2Lp-treated and -untreated HM3KO cells stained with acridine
orange-ethidium bromide (AO-EB). HM3KO cells were treated with 7.59μg/mL SF2Lp for 24 (b), 48 (c), and 72 (d) hours. DMSO-treated
HM3KO cells served as negative control (a). SF2Lp-treated cells showed signiﬁcant morphological changes including nuclear condensation
(blue arrows), membrane blebbing (yellow arrows), and apoptotic bodies (green arrows). Magniﬁcation for (a): 400x; (b)–(d): 1000x.
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from three independent experiments. SF2Lp-induced HM3KO cell death via apoptosis increased signiﬁcantly in a time-dependent manner
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Figure 5: Cellcycle distributioninHM3KO cells treated with SF2Lp at 3μg/mL (SF2LP-3), 7.59μg/mL (SF2LP-7.59), and 15μg/mL (SF2LP-
15) for 24 hours. DMSO-treated cells were used as control. The data represent the mean ± SD of 3 independent experiments. ∗Signiﬁcantly
diﬀerent at P<0.05 when the treated group was compared with the control.
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Figure 6: The G1/S index in growing HM3KO cells treated with SF2Lp at 3μg/mL (SF2LP-3), 7.59μg/mL (SF2LP-7.59), and 15μg/mL
(SF2LP-15) for 24 hours. DMSO-treated cells were used as control. The data represent the mean ± SD of 3 independent experiments.
∗Signiﬁcantly diﬀerent at P<0.05 when the treated group was compared with the control.
group, respectively, of the G2/M phase cells (P<0.05). After
a 24-hour exposure to SF2Lp, the G1/S ratio of the treatment
group was signiﬁcantly higher than that of the control group
(P<0.05). A constant increasing pattern of the G1/S index
was observed in the treatment group while the G1/S ratio of
thecontrolgroupwasdecreasing concomitantlythrough10–
24h treatment. After a 24-hour exposure to SF2Lp, the G1/S
index of HM3KO cells was 2.3 to 3.6 times higher than that
of the control group (Figure 6).
These observations clearly suggest that the active fraction
of L. pumila, SF2Lp, was able to alter the cell cycle distri-
bution of the growing HM3KO cells in a dose-dependent
manner. In addition, after 24 hours of treatment, SF2Lp had
caused a signiﬁcant increased in cell numbers in G1 phase
together with a marked reduction of the cell populations in S
phase indicating that SF2Lp can eﬀectively suppress HM3KO
cells growth and proliferation by arresting the cell cycle at
G1/S transition phase.
3.4. L. pumila Active Fraction, SF2Lp, Induced Expression of
p53 and Its Downstream Regulator Bax and Suppressed the
Antiapoptotic Bcl-2 Expression. The p53 protein plays a vital
role in apoptosis and lack of its expression or function may
increased the risk of tumor formation [32]. To determine the
role of p53 in the induction of apoptosis in HM3KO cells by
SF2Lp, the total p53 protein levels was assessed by Western
blot analysis.
In this study, the results obtained showed that the
expression level of p53 in SF2Lp-treated HM3KO cells was
signiﬁcantly increased (P<0.05) after 6 hours of exposureEvidence-Based Complementary and Alternative Medicine 9
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Figure 7: Representative Western blots showing the eﬀect of SF2Lp at its IC50 concentration (7.59μg/mL) on expression level of p53 in
HM3KO cells at diﬀerent time intervals (3, 6, 12, and 24 hours). To conﬁrm equal loading, the membrane was reprobed with β-actin. The
data represent the mean ± SD of 3 independent experiments. ∗Signiﬁcantly diﬀerent at P<0.05 over control group.
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Figure 8: Representative Western blots showing the eﬀect of SF2Lp at its IC50 concentration (7.59μg/mL) on the expression level of
proapoptotic Bax in HM3KO cells at diﬀerent time intervals (3, 6, 12, and 24 hours). To conﬁrm equal loading, the membrane was reprobed
with β-actin. The data represent the mean ± SD of 3 independent experiments. ∗Signiﬁcantly diﬀerent at P<0.05 over control group.
with SF2Lp at its IC50 concentration (7.59μg/mL) and the
level was found maximum after 24-hour treatment with
S F 2 L pa sc o m p a r e dt oc o n t r o l( Figure 6). This observation
suggests that SF2Lp-induced apoptosis of HM3KO cells
could be mediated through a p53-dependent pathway (Fig-
ure 7).
In the next part of the experiment, results from the
Western blot analysis showed that SF2Lp treatment at its
IC50 concentration (7.59μg/mL) was able to concurrently
increase the expression level of proapoptotic protein Bax
and reduce the expression level of antiapoptotic protein BCl-
2 in HM3KO cells in a time-dependent manner (Figures
8 and 9), directly contributing to the increase in Bax/Bcl-
2r a t i o( Figure 10). As shown in Figure 8,a f t e r6h o u r s
of treatment, SF2Lp was found to be able to increase the
Bax protein levels in HM3KO cells treated with 7.59μg/mL
of SF2Lp, while the antiapoptotic Bcl-2 protein levels were
found decreased and this was evident after 12 hours of
treatment with SF2Lp. According to Cory et al. [33], the
susceptibility of tumor cells to the induction of apoptosis by
chemotherapeutic agents is controlled by the ratio of Bcl-
2/Bax proteins in the mitochondria. Thus, these ﬁndings
suggest that the increased Bax/Bcl-2 ratio together with a
marked increase in the level of p53 protein expression, in
part, may contribute to the induction of apoptosis in SF2Lp-
treated HM3KO cells through a p53-dependent apoptotic
pathway.
4. Discussion
The objective of this study was to evaluate the antiprolifera-
tive eﬀect of L. pumila extracts in HM3KO cells proliferation
andtoelucidatethepossiblemolecularmechanismsthatmay
occur as a result of exposing HM3KO cells with SF2Lp.
Both cell proliferation and apoptotic cell death are im-
portant determinants of growth of a tumour [5]. A balance
betweenthetwoiscriticalinmaintainingtissueshomeostasis
and normal development. As many chemotherapeutic agents10 Evidence-Based Complementary and Alternative Medicine
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Figure 9: Representative Western blots showing the eﬀect of SF2Lp at its IC50 concentration (7.59μg/mL) on the expression level of
antiapoptotic Bcl-2 in HM3KO cells at diﬀerent time intervals (3, 6, 12, and 24 hours). To conﬁrm equal loading, the membrane was
reprobed with β-actin. The data represent the mean ± SD of 3 independent experiments. ∗Signiﬁcantly diﬀerent at P<0.05 over control
group.
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Figure 10: Eﬀects of L. pumila active fraction, SF2Lp, at is IC50 concentration (7.59μg/mL) on the Bax/Bcl-2 ratio in HM3KO cells at
diﬀerent time intervals (3, 6, 12, and 24 hours). The data represent the mean ± SD of 3 independent experiments. ∗Signiﬁcantly diﬀerent at
P<0.05 over control group.
have been identiﬁed to be able to induce apoptosis in
cancer cells [34–36], apoptosis has been considered as a
method for the treatment of cancer. Altered apoptosis, how-
ever, may contribute to development of cancer and other
primary human diseases such as autoimmune diseases
and neurodegenerative disorders [8, 37, 38]. Observation
of morphological changes as cells undergo apoptosis still
remains the most reliable technique to deﬁne apoptotic cell
death [39]. Even though light microscopy has a low capacity
to distinguish apoptotic cells, the acuity can be enhanced
by using nuclear ﬂuorescent dyes to examine nuclear
c h a n g e ss u c ha sc o m p a c t e dc h r o m a t i na n df r a g m e n t e d
DNA.
This study has demonstrated that the treatment of
HM3KO cells with L. pumila extracts resulted in an inhi-
bition of cell proliferation and a concomitant decrease in
cell viability. Results obtained from the study suggested
that among the various (aqueous-LpAE, ethanolic-LpEE,
and hexane-LpHE) L. pumila extracts tested, LpEE showed
the highest antiproliferative activity against HM3KO cells.
Interestingly, the cytotoxicity of LpEE appeared to be higher
against HM3KO cells than on nonmalignant MDBK and
Vero cell lines. The 50% inhibitory concentration (IC50)o f
LpEE against HM3KO cells was 16.18 ± 0.94μg/mL, while
its active fraction, SF2Lp, showed lower values that is 7.59 ±
0. 0.53μg/mL. From this point onwards, SF2Lp was used
to further elucidate the molecular mechanism involved in
SF2Lp-induced HM3KO cells apoptosis. Findings from the
antiproliferative and apoptosis assays suggest that SF2Lp was
able to induced cell death of HM3KO cells.
To conﬁrm that SF2Lp-treated cell death was through
apoptosis, the extent of cell death was investigated by using
nuclear staining assays and Apoptotic Index (AI) was then
calculated. AI can be deﬁned as the percentage of apoptoticEvidence-Based Complementary and Alternative Medicine 11
cells and apoptotic bodies within the overall population of
total cells [26].
Results from the Giemsa staining assays clearly show the
morphology of apoptotic HM3KO cells and the apoptotic
cells can be seen only after 24 hours of treatment (Figure 2).
The ability of SF2Lp in inducing apoptotic cell death
in HM3KO cells was conﬁrmed by the acridine orange-
ethidium bromide (AO-EB) nuclear staining assay that dis-
played presence of obvious changes associated with apop-
tosis, which include cell shrinkage, condensation of nuclear
chromatin, and apoptotic bodies in SF2Lp-treated cells. The
Apoptotic Index (AI) calculated from AO-EB assay further
revealed that the percentage of apoptotic HM3KO cells
that have been treated with 7.59μg/mL of L. pumila active
fraction, SF2Lp, were increased in a time-dependent manner
with 29.5 ± 1.6% at 24 hours, 54.1 ± 1.1% at 48 hours,
and 69.8 ± 1.7% at 72 hours. This observation indicated
that the longer the exposure time to SF2Lp, the higher the
percentageofapoptoticHM3KOcells.Theseﬁndingssuggest
that antiproliferative eﬀect of SF2Lp in HM3KO cells was
via induction of apoptosis and that the active components
present in SF2Lp have the ability to induce cancer cell death
in vitro.
Many anticancer molecules show growth inhibition
and/or apoptotic cell death of cancer cells by modulating
the cell-cycle regulatory molecules [40]. To ﬁnd out the
mechanism of action of SF2Lp in inhibiting the HM3KO
cells’ growth, the eﬀects of SF2Lp on the cell cycle and its
ability to induce apoptosis in HM3KO cells were studied.
Results obtained from the ﬂow cytometry analysis showed
that SF2Lp was able to arrest the cell cycle at the G1 phase
to prevent the HM3KO cells transition from G1 to S phase.
The ability of SF2Lp to arrest the cell cycle and to induce the
apoptosis process in HM3KO cells is believed to contribute
to the antiproliferative activity of SF2Lp.
In order to examine the mechanism of action of SF2Lp
in inducing apoptosis in HM3KO cells at the molecular level,
Western blotting analysis was thus carried out. Results from
themechanisticstudyshowedthatSF2Lpwasabletoconcur-
rently increase the expression level of proapoptotic protein
Bax and reduce the expression level of antiapoptotic protein
in HM3KO cells. This phenomenon is directly contributing
to the increase in Bax/Bcl-2 ratio that drives cells to undergo
apoptosis [33]. To ﬁnd out whether apoptosis induction
by SF2Lp involves the tumor suppressor protein p53, the
eﬀect of SF2Lp on the expression level of p53 was also
studied. Results from the Western blotting analysis showed
that SF2Lp was able to increase the expression level of p53
in HM3KO cells. These ﬁndings suggest that the ability of
SF2Lp to arrest the cell cycle at G1 phase and to induce the
apoptosis process in HM3KO cells was possibly mediated by
the activity of p53.
All in all, the above-mentioned ﬁndings suggest that the
increased Bax/Bcl-2 ratio together with a marked increase in
the level of p53 protein expression, in part, may contribute
to the antiproliferative activity and induction of apoptosis
in SF2Lp-treated HM3KO cells through a p53-dependent
apoptotic pathway.
There are very limited numbers of scientiﬁc papers pub-
lished regarding the inhibitory eﬀects of L. pumila towards
cell proliferation as well as apoptosis induction in cultured
cells. To the best of our knowledge, the present study is the
ﬁrst to report the antiproliferative and proapoptotic eﬀects
of L. pumila ethanol extract and its active fraction, SF2Lp, in
human melanoma HM3KO cells in vitro.
5. Conclusion
Altogether the results from this study, showed antiprolifera-
tive eﬀects of L. pumila active fraction, SF2Lp, through the
regulation of the cell cycle progression and the expression
of proteins involved in apoptotic pathway in HM3KO cells.
From this study we can conclude that L. pumila was able
to inhibit HM3KO cell growth possibly by arresting the cell
cycle at G1 phase and inducing apoptosis in HM3KO cells
via the up- and down-regulation of Bax/Bcl-2 protein, which
mediated through a p53-dependent pathway.
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